SCIENTIFIC AGENDA

Click here to view activity

Current Therapeutic Options and Combinations for Advanced Melanoma
Mark R. Middleton, PhD, MRCP

Vaccines and Immunotherapy: Current Status and a Look Forward
Jurgen C. Becker, MD, PhD

Targeting the CTLA4 Receptor to Enhance T-cell Activation Against Melanoma
Alexander M.M. Eggermont, MD, PhD

Emerging Agents and Approaches to Targeted Therapy for Melanoma
Celeste Lebbe, MD, PhD